Go to deals
Consumer & Retail

Obagi Cosmeceuticals has raised unitranche debt

Obagi Cosmeceuticals LLC has completed its recapitalization and growth financing. The financing facility was provided by the private credit group of TCW Asset Management Company LLC, a leading private credit lender with over US$5 billion of capital under management that specializes in providing senior-secured loans to US-based middle-market borrowers.

Headquartered in Long Beach, California, Obagi is a women-led independent global skincare company dedicated to providing advanced, clinically-proven skincare treatments for all skin types. The company provides more than 100 Obagi Medical® products to brighten, nourish, protect and enhance skin tone and texture through an extensive network of distributors, partners, physician offices and spas around the world, as well as its newly launched direct-to-consumer (DTC) platform. Obagi also offers dermatologist-tested, technologically advanced formulas through its Obagi Clinical™ line, accessible to consumers through Sephora.

Oaklins’ team in Los Angeles initiated this transaction, assisted in the negotiations and served as the financial advisor to Obagi Cosmeceuticals.

“Oaklins’ team in Los Angeles did a phenomenal job managing the transaction process and negotiating a deal that sets Obagi up for success. Their team understood how to position our company’s massive opportunity to secure a financing structure that far exceeded our expectations.”

Jaime Castle

President and CEO, Obagi Cosmeceuticals LLC

Talk to the deal team

 Jonathan  Zucker

Jonathan Zucker

Managing Director
Los Angeles, United States
Oaklins Intrepid
 Kevin  Striepe

Kevin Striepe

Associate Director
Los Angeles, United States
Oaklins Intrepid
 Joseph  Wisniewski

Joseph Wisniewski

Associate Director
Los Angeles, United States
Oaklins Intrepid

Related deals

Apotheka acquires two pharmacy outlets from Panpharmacy
Consumer & Retail | Healthcare

Apotheka acquires two pharmacy outlets from Panpharmacy

In a strategic move that signifies the ongoing consolidation and growth within the Latvian pharmaceutical retail sector, Panpharmacy, the parent company of the leading online pharmacy InternetAptieka.lv, has successfully completed the sale of two of its brick-and-mortar pharmacies to Apotheka. These pharmacies, both situated in the capital city of Riga, will continue to serve customers under the Apotheka brand, marking a seamless transition in ownership and operations.

Learn more
Omnetic, member of EAG Group, has raised growth capital from Kartesia and CVI
Automotive | TMT

Omnetic, member of EAG Group, has raised growth capital from Kartesia and CVI

EAG Group has completed a first investment round for its Omnetic platform. The company was seeking growth capital of up to US$110 million in order to consolidate the CEE markets and finance its expansion to new geographies. The transaction was closed with Kartesia, the European specialist provider of capital solutions for small- and mid-sized companies, in partnership with CVI, a private debt investor based in Warsaw, Poland.

Learn more
JL&P has received a minority investment from Arkéa Capital and Swen Capital Partners
Private Equity | Construction & Engineering Services | Energy

JL&P has received a minority investment from Arkéa Capital and Swen Capital Partners

JL&P Group has completed a primary minority LBO with Arkéa Capital and Swen Capital Partners.

Learn more